Sagimet Biosciences Inc (NASDAQ: SGMT) started the day on Wednesday, with a price increase of 3.64% at $6.27, before settling in for the price of $6.05 at the close. Taking a more long-term approach, SGMT posted a 52-week range of $1.73-$11.41.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -16.85%. Meanwhile, its Annual Earning per share during the time was -16.85%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -16.36%. This publicly-traded company’s shares outstanding now amounts to $31.00 million, simultaneously with a float of $26.33 million. The organization now has a market capitalization sitting at $194.38 million. At the time of writing, stock’s 50-day Moving Average stood at $7.39, while the 200-day Moving Average is $6.29.
Sagimet Biosciences Inc (SGMT) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Sagimet Biosciences Inc’s current insider ownership accounts for 19.03%, in contrast to 32.77% institutional ownership. According to the most recent insider trade that took place on Nov 20 ’25, this organization’s Executive Chairman sold 37,688 shares at the rate of 7.69, making the entire transaction reach 289,979 in total value, affecting insider ownership by 81,005.
Sagimet Biosciences Inc (SGMT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
Sagimet Biosciences Inc’s EPS decrease for this current 12-month fiscal period is -16.36% and is forecasted to reach -1.94 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -12.25% through the next 5 years, which can be compared against the -16.85% growth it accomplished over the previous five years trading on the market.
Sagimet Biosciences Inc (NASDAQ: SGMT) Trading Performance Indicators
Let’s observe the current performance indicators for Sagimet Biosciences Inc (SGMT). It’s Quick Ratio in the last reported quarter now stands at 13.04. In the same vein, SGMT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.79, a figure that is expected to reach -0.42 in the next quarter, and analysts are predicting that it will be -1.94 at the market close of one year from today.
Technical Analysis of Sagimet Biosciences Inc (SGMT)
If we take a close look at the recent performances of Sagimet Biosciences Inc (NASDAQ: SGMT), its last 5-days Average volume was 0.76 million that shows plunge from its year to date volume of 0.91 million. During the previous 9 days, stock’s Stochastic %D was recorded 37.02% While, its Average True Range was 41.61.
Raw Stochastic average of Sagimet Biosciences Inc (SGMT) in the period of the previous 100 days is set at 11.22%, which indicates a major fall in contrast to 33.22% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.42 that was lower than 0.55 volatility it exhibited in the past 100-days period.
